Evidence map›Paper›PMID 31199790›Full record

ArticlePLoS genetics2019

The gene regulatory basis of genetic compensation during neural crest induction.

Christopher M Dooley, Neha Wali, Ian M Sealy, Richard J White, Derek L Stemple, John E Collins, Elisabeth M Busch-Nentwich

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Christopher M DooleyWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
Neha WaliWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
Ian M SealyWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.ORCID 0000-0002-2890-6635
Richard J WhiteWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
Derek L StempleWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.ORCID 0000-0002-8296-9928
John E CollinsWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
Elisabeth M Busch-NentwichWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.ORCID 0000-0001-6450-744X
Wellcome Sanger Institute · GBUniversity of Cambridge · GB

Funding

Wellcome TrustWellcome Trust 098051Wellcome Trust 206194
6 · The paper itself

Abstract

The neural crest (NC) is a vertebrate-specific cell type that contributes to a wide range of different tissues across all three germ layers. The gene regulatory network (GRN) responsible for the formation of neural crest is conserved across vertebrates. Central to the induction of the NC GRN are AP-2 and SoxE transcription factors. NC induction robustness is ensured through the ability of some of these transcription factors to compensate loss of function of gene family members. However the gene regulatory events underlying compensation are poorly understood. We have used gene knockout and RNA sequencing strategies to dissect NC induction and compensation in zebrafish. We genetically ablate the NC using double mutants of tfap2a;tfap2c or remove specific subsets of the NC with sox10 and mitfa knockouts and characterise genome-wide gene expression levels across multiple time points. We find that compensation through a single wild-type allele of tfap2c is capable of maintaining early NC induction and differentiation in the absence of tfap2a function, but many target genes have abnormal expression levels and therefore show sensitivity to the reduced tfap2 dosage. This separation of morphological and molecular phenotypes identifies a core set of genes required for early NC development. We also identify the 15 somites stage as the peak of the molecular phenotype which strongly diminishes at 24 hpf even as the morphological phenotype becomes more apparent. Using gene knockouts, we associate previously uncharacterised genes with pigment cell development and establish a role for maternal Hippo signalling in melanocyte differentiation. This work extends and refines the NC GRN while also uncovering the transcriptional basis of genetic compensation via paralogues.

Indexed as

AnimalsCell DifferentiationCell LineageEmbryonic DevelopmentEmbryo, NonmammalianGene Expression Regulation, DevelopmentalGene Regulatory NetworksHippo KinasesMelanocytesMicrophthalmia-Associated Transcription FactorNeural CrestPigmentationProtein Serine-Threonine KinasesSerine-Threonine Kinase 3SOXE Transcription FactorsTranscription Factor AP-2Hippo KinasesMicrophthalmia-Associated Transcription Factormitfa protein, zebrafishProtein Serine-Threonine KinasesSerine-Threonine Kinase 3sox10 protein, zebrafishSOXE Transcription Factorsstk3 protein, zebrafishtfap2a protein, zebrafishTranscription Factor AP-2Zebrafish Proteins

Identifiers

PMID31199790
PMCPMC6594659
OpenAlexW2951612984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.